Avaleht/Aktsiad/TWST

TWST

USD

Twist Bioscience Corporation Common Stock

$30.060-0.970 (-3.126%)

Reaalajas hind

Healthcare

Diagnostics & Research

Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$31.030

Kõrge

$31.390

Madal

$29.715

Maht

1.91M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.8B

Tööstusharu

Diagnostics & Research

Riik

United States

Kauplemisstatistika

Keskmine maht

1.74M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $24.07Praegune $30.060Kõrge $55.33

Seotud uudised

4. nov 2025 · 13:04

Analyst Upgrades

Stephens & Co. Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $41

Stephens & Co. analyst Steven Etoch initiates coverage on Twist Bioscience with a Overweight rating and announces Price Target of $41.

Vaata rohkem

Stephens & Co. Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $41

4. nov 2025 · 13:00

BusinessWire

Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

Twist Bioscience Corporation (NASDAQ:TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist, will

Vaata rohkem

Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

3. nov 2025 · 13:00

BusinessWire

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ:TWST) ("Twist" or the "Company"), a mid-cap growth and value biotech company, today announced that it has granted a total of

Vaata rohkem